Because the injections are: Medically necessary Related to a covered condition Administered in a clinical environment Medicare Part B covers 80% of the expenses
Mousa SA, Al Momen A, Al Sayegh F, Al Jaouni S, Nasrullah Z, Al Saeed H,
Compounded or custom peptides are not FDA-approved but are regulated to ensure quality and sterility but are not approved for medical purposes
Effects of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial Tesamorelin, a growth hormone-releasing factor analogue, in HIV-infected patients with excess abdominal fat Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in HIV-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials Pharmacokinetics, pharmacodynamics, and safety of ipamorelin, a novel ghrelin mimetic peptide, in healthy volunteers Ipamorelin, the first selective growth hormone secretagogue Growth hormone-releasing hormone in the treatment of HIV-associated lipodystrophy Eligibility & terms of sale This material is sold to qualified laboratory and research buyers for lawful research use only
This is also true for high Hcy levels [110]
